Website Changes
11/20/2015
ImmunoCellular Therapeutics Ltd Presents Updated ICT-107 Phase 2 Survival and Immune Response Data at the Society for Neuro-Oncology Annual Meeting 2015
11/18/2015
CURE Media Group’s Heroes of Glioblastoma Announced Today
11/18/2015
IBTA E-News
11/17/2015
Global brain cancer trial aims to rapidly respond to new treatments
11/17/2015
Drug That Could Limit Spread of Deadly Brain Tumours
11/17/2015
Novocure Announces 18 Presentations on Tumor Treating Fields at SNO 2015 Including New Analyses of the EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data
11/07/2015
Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.
11/07/2015
Toca5: A Phase 2/3 Randomized, Open Label Study of Toca 511™, a Retroviral Replicating Vector,
Combined With Toca FC™ versus Standard of Care in Subjects Undergoing Planned
Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
11/06/2015
Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor
11/04/2015
No Impact With Mifepristone in Patients With Meningioma
10/30/2015
IBTA News
10/30/2015
Swedish Medical Center in Seattle announces a clinical trial in humans for the treatment of glioblastoma
10/30/2015
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.
10/14/2015
Cancer drug’s effectiveness overinflated in animal studies
10/14/2015
Dr. Jim Olson: How to defeat cancer, with help from nature, scorpions and innovative thinking
10/14/2015
Santosh Kesari, M.D., Ph.D., F.A.N.A, F.A.A.N., has joined the Pacific Brain Tumor Center and the John Wayne Cancer Institute at Providence Saint John’s Health Center in Santa Monica,
10/13/2015
Video Games Can Improve Cancer Survivors’ Cognitive Abilities
10/11/2015
New book about a husband and wife who both had brain tumors is raising money for brain tumor research!
10/11/2015
Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
10/08/2015
A new way to donate without it costing you a penny!
10/08/2015
VBI Vaccines Announces Development of a Novel Glioblastoma Immunotherapy Candidate
10/05/2015
Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
10/05/2015
Musella Foundation Copayment Assistance program has reopened!
10/05/2015
FDA Expands Optune`s Glioblastoma Multiforme Indication
10/05/2015
Musella Foundation Drug Discount Card Update
which delivers brain tumor news and additions
to the website via RSS.